Groupement Pharmaceutique de l'Union Europ… AISBL
4.5 FTEGroupement Pharmaceutique de l'Union Europ… reported total assets of €2.69m at the end of the 2025 financial year (annual accounts filed with the NBB on 23 Jul 2026), with 4.5 full-time equivalents.
By total assets for 2025, Groupement Pharmaceutique de l'Union Europ… ranks in the top half of the 318 companies in its sector (NACE 9411) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Groupement Pharmaceutique de l'Union Europ… shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +15 % Total assets +64 % Headcount (avg FTE) +5 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Groupement Pharmaceutique de l'Union Europ…'s annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 23 Jul 2026
- Year ended 31 Dec 2024filed on 25 Aug 2025
- Year ended 31 Dec 2023filed on 14 Jun 2024
- Year ended 31 Dec 2022filed on 07 Jul 2023
- Year ended 31 Dec 2021filed on 14 Jul 2022
Groupement Pharmaceutique de l'Union Europ…'s financial analysis
- Solvency65.0%sector median: 69.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Groupement Pharmaceutique de l'Union Europ…
10 active director(s) in the register.
and 4 more
Groupement Pharmaceutique de l'Union Europ…'s shareholders and holdings →Groupement Pharmaceutique de l'Union Europ…'s publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0468.971.838
- VAT number
- BE0468971838
- Peppol
- Registered · 0208:0468971838 · as of 10 Nov 2026
- Legal form
- AISBL
- Incorporated
- 13 Jan 2000
- Registered office
- 1000 Brussels
- Size
- Micro · 4.5 FTE
- Latest accounts
- 2025 · filed on 23 Jul 2026
- Activity
- Activities of business and employers membership organisations (NACE 94110)
Groupement Pharmaceutique de l'Union Europ… (AISBL) has been based in Brussels since 2000, active in: activities of business and employers membership organisations. For 2025, it reports a net loss of 1,939 € and equity of €1.75m; its revenue is not published. With 4.5 full-time equivalents, it is a micro-enterprise by headcount.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Groupement Pharmaceutique de l'Union Europ…
Companies in the same business, of comparable size and area, outside its group.
- Federation des Chambres de Commerce Belges - Federatie van Belgische Kamers van Koophandel Activities of business and employers membership organisations Etterbeek · balance sheet €2.78m
- European Association of Co-operative Banks Activities of business and employers membership organisations Brussels · balance sheet €2.34m
- Comité des Associations d'Armateurs des Communautés européennes Activities of business and employers membership organisations Brussels · balance sheet €3.18m
- Eurohealthnet Activities of business and employers membership organisations Brussels · balance sheet €2.61m
- Unie van socialprofitondernemingen Activities of business and employers membership organisations Brussels · balance sheet €2.95m
- Detergents Europe Activities of business and employers membership organisations Auderghem · balance sheet €4.08m
- Forum Atomique Europeen Activities of business and employers membership organisations Brussels · balance sheet €2.42m
- Centr Activities of business and employers membership organisations Etterbeek · balance sheet €2.37m
Frequently asked questions about Groupement Pharmaceutique de l'Union Europ…
What is the revenue of Groupement Pharmaceutique de l'Union Europ…?
Groupement Pharmaceutique de l'Union Europ… files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Groupement Pharmaceutique de l'Union Europ…?
In Belgium, the VAT number is the company number prefixed with BE: BE0468971838 for Groupement Pharmaceutique de l'Union Europ…, if the company is VAT-registered. Its company number (CBE) is 0468.971.838.
Where is the registered office of Groupement Pharmaceutique de l'Union Europ…?
According to the CBE register, the registered office of Groupement Pharmaceutique de l'Union Europ… is in 1000 Brussels.
What is the equity of Groupement Pharmaceutique de l'Union Europ…?
At the close of the 2025 financial year, the equity of Groupement Pharmaceutique de l'Union Europ… amounts to 1,751,663 €, a solvency of 65.0% of total assets.
How many people work at Groupement Pharmaceutique de l'Union Europ…?
4.5 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Groupement Pharmaceutique de l'Union Europ…?
The register lists 10 active mandates at Groupement Pharmaceutique de l'Union Europ…. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Groupement Pharmaceutique de l'Union Europ… within its sector?
By total assets for 2025, Groupement Pharmaceutique de l'Union Europ… ranks in the top half of the 318 companies in its sector (NACE 9411) in Belgium that filed accounts for that financial year.
The full file of Groupement Pharmaceutique de l'Union Europ…
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →